FISES Archivos

Foro sobre Fisica Estadistica

FISES@LISTSERV.REDIRIS.ES

Opciones: Vista Forum

Use Monospaced Font
Mostrar las partes HTML
Esconda cabeceras de correo

Mensaje: [<< Primero] [< Prev] [Siguiente >] [Último >>]
Tema: [<< Primero] [< Prev] [Siguiente >] [Último >>]
Autor: [<< Primero] [< Prev] [Siguiente >] [Último >>]

Print Responder
Received:
by LISTSERV.REDIRIS.ES (LISTSERV-TCP/IP release 16.0) with spool id 11514030 for [log in para visualizar]; Mon, 27 Apr 2020 14:22:10 +0200 from mx02.puc.rediris.es (outbound5sev.lav.puc.rediris.es [130.206.19.180]) by listserv.rediris.es (Postfix) with ESMTP id 1E00823264 for <[log in para visualizar]>; Mon, 27 Apr 2020 14:09:25 +0200 (CEST) from mail-pl1-x62f.google.com (mail-pl1-x62f.google.com [IPv6:2607:f8b0:4864:20::62f]) by mx02.puc.rediris.es with ESMTP id 03RC9Mb9015620-03RC9MbB015620 (version=TLSv1.3 cipher=TLS_AES_256_GCM_SHA384 bits=256 verify=CAFAIL) for <[log in para visualizar]>; Mon, 27 Apr 2020 14:09:24 +0200 by mail-pl1-x62f.google.com with SMTP id v2so6918495plp.9 for <[log in para visualizar]>; Mon, 27 Apr 2020 05:09:23 -0700 (PDT)
Sender:
Foro sobre Fisica Estadistica <[log in para visualizar]>
References:
Date:
Mon, 27 Apr 2020 14:09:09 +0200
X-FEAS-SPF:
spf-result=pass, ip=2607:f8b0:4864:20::62f, helo=mail-pl1-x62f.google.com, [log in para visualizar]
X-Google-DKIM-Signature:
v=1; a=rsa-sha256; c=relaxed/relaxed; d=1e100.net; s=20161025; h=x-gm-message-state:mime-version:references:in-reply-to:from:date :message-id:subject:to; bh=P6N+ME9KgjYHCGEUDKP0Y7Z+T+YLCVSxWsrR51WbfNU=; b=Ad9Rxt1m1JbUVx1vMxmMbPViBfmYsNpm+CEj/zF04sGJc50nSXUN+b9tJ12em0mwYG YFcNgQ1AO3bd1cBwT75JsMsavIai40V6l9v2aFwv5Ydj2wWvsaPRLo2WCEEUmiNSDgOA Ga8YODJ4bkyFKTVYj8oisLOfvwT56a6mkMkKiEZW11TKdGBEehhya4shE/KL7rWML/fC ID2ynfDEd0OCnkZKrr75Mf3PQJBf/r8HujfzkQ3atSTy9U+BK/5D4AWI9FF0HmdW8WKb 49aj4ZLRGfftIjieU4sq/cmEl6R6xXYasXe6Ug8Gi0Ddd/Syl6jVDUxWl8LBJRYCK9DO rsFg==
Message-ID:
MIME-Version:
1.0
X-Received:
by 2002:a17:90a:3707:: with SMTP id u7mr22352554pjb.182.1587989361432; Mon, 27 Apr 2020 05:09:21 -0700 (PDT)
X-FEAS-DKIM:
Valid
X-Google-Smtp-Source:
APiQypIyAzS2B3cxSU34PQico8kxRUbns9Jko/IezSjyinRBD6RThre6+Fj0q6eMmDEcwNDOphEAlT2NmAMmgyPM5Nc=
X-Gm-Message-State:
AGi0PuYiiuU6XPY7lqHPeDv8dQdYw9kf/bAHLS6pFts7PWQKKaFdW6ms RR8Uq5++eNtZ0hpqwYyEGqsY5OdgbNEZwligo5TPBsSR
Content-Type:
multipart/alternative; boundary="000000000000cb9ba105a44495ad"
Delivered-To:
Emisor:
Alberto Pascual <[log in para visualizar]>
Subject:
In-Reply-To:
Reply-To:
Alberto Pascual <[log in para visualizar]>
Approved-By:
Parts/Attachments:
text/plain (5 kB) , text/html (24 kB)
Para los interesados en COVID, desde la plataforma
https://crowdfightcovid19.org/  estamos empezando a recopilar activamente
links (pestaña "resources") que puede ser de ayuda (incluiremos tus links
Ignacio),

Un saludo,

Alberto

El lun., 27 abr. 2020 a las 13:11, Ignacio Pagonabarraga (<
[log in para visualizar]>) escribió:

> Hola a todos,
>
> Os envío al final de este mensaje el anuncio de la segunda sesión de una
> serie de webinarios que organizamos  desde CECAM sobre los desafíos que
> plantea CoVid-19 y las respuestas que se le pueden dar desde la simulación
> y modelización, y que tendrá lugar manana martes 28 a las 15:00.
>
> Atentamente,
> Ignacio Pagonabarraga
>
>
>
>
>
> CECAM Webinars
>
>
>
> Dear Friends and Colleagues,
>
> The second CECAM webinar on
>
> *CoVid-19: challenges and responses in simulation, modeling and beyond*
>
> will be broadcasted live on *Tuesday April 28 15:00-16:45 CEST* at
>
> https://www.youtube.com/watch?v=cFwy9NVz-gE
>
> This time, we shall focus on the Excalate4CoV project
> <https://www.exscalate4cov.eu/>, one of the EU funded initiatives to
> deploy high-end computational resources in the research on Coronavirus.
>
> Program:
>
> 15:00   Welcome and Introduction, Prof. Ignacio Pagonabarraga (CECAM)
>
> 15:10   Andrea Beccari (DOMPE FARMACEUTICI SPA): Exscalate4CoV, an
> introduction
>
> 15:20   Carmine Talarico (DOMPE FARMACEUTICI SPA): The computational Task
> in Exscalate4CoV
>
> 15:40   Coffe-e-break
>
> 15:50   Giulia Rossetti (Forschungszentrum Jülich and RWTH Aachen):
> Computational approaches to drug repurposing
>
> 16:20   Questions and Answers
>
> If you have a YouTube or Google account, you will be able to ask questions
> during the talks using a chat. You can also send your questions via email
> to [log in para visualizar] A moderator will relay as many of these questions
> as possible to the speakers.
>
> The third webinar of the series is scheduled for May 5th, at the same
> time. As always, we are open to input from the community and we would be
> glad to extend the initiative.
>
> More information on the series and up to date videos can be found at:
>
> https://www.cecam.org/cecam-webinars
>
> Other EU actions for supercomputing as a tool to help find a treatment are
> here
> <https://ec.europa.eu/digital-single-market/en/news/using-european-supercomputing-treat-coronavirus>
>
> Be well,
>
> the CECAM team in Lausanne
>
> P.S. Webinars are still a new adventure for CECAM. Our first attempt was
> reasonably smooth, but Mr. Murphy and his law may yet lay in ambush and
> things can go wrong in a live broadcast. Should there be serious problems
> on Tuesday we ask for your understanding. All seminars will be recorded and
> will be available long-term on the CECAM website.
>
> P.P.S. If you do not wish to receive news on the CECAM webinars, click on
> unsubscribe below.
>
>
>
>
>
>
> [image: Website] <https://www.cecam.org>
>
> [image: Facebook] <https://www.facebook.com/cecam.org>
>
> [image: Twitter] <https://twitter.com/cecamEvents>
>
>
>
>
>
> © Copyright 2020 CECAM, Lausanne Switzerland.
>
> Unsubscribe
> <https://dmanalytics1.com/delivery-unsubscribe?d=4764-5h6RYaP2zeaG0NLSQ&e=ignacio.pagonabarraga%40epfl.ch&a=STViDDlyRxOlItW3VJZP2w&f=>
>  • Update Email Address
> <https://dmanalytics1.com/delivery-update-email?d=4764-5h6RYaP2zeaG0NLSQ&e=ignacio.pagonabarraga%40epfl.ch&a=STViDDlyRxOlItW3VJZP2w&f=>
>  • View Online
> <https://dmanalytics1.com/campaign?d=4764-5h6RYaP2zeaG0NLSQ&e=ignacio.pagonabarraga%40epfl.ch&a=STViDDlyRxOlItW3VJZP2w&f=&t=>
>
>
>
>
> Aquest missatge, i els fitxers adjunts que hi pugui haver, pot contenir
> informació confidencial o protegida legalment i s’adreça exclusivament a la
> persona o entitat destinatària. Si no consteu com a destinatari final o no
> teniu l’encàrrec de rebre’l, no esteu autoritzat a llegir-lo, retenir-lo,
> modificar-lo, distribuir-lo, copiar-lo ni a revelar-ne el contingut. Si
> l’heu rebut per error, informeu-ne el remitent i elimineu del sistema tant
> el missatge com els fitxers adjunts que hi pugui haver.
>
> Este mensaje, y los ficheros adjuntos que pueda incluir, puede contener
> información confidencial o legalmente protegida y está exclusivamente
> dirigido a la persona o entidad destinataria. Si usted no consta como
> destinatario final ni es la persona encargada de recibirlo, no está
> autorizado a leerlo, retenerlo, modificarlo, distribuirlo o copiarlo, ni a
> revelar su contenido. Si lo ha recibido por error, informe de ello al
> remitente y elimine del sistema tanto el mensaje como los ficheros adjuntos
> que pueda contener.
>
> This email message and any attachments it carries may contain confidential
> or legally protected material and are intended solely for the individual or
> organization to whom they are addressed. If you are not the intended
> recipient of this message or the person responsible for processing it, then
> you are not authorized to read, save, modify, send, copy or disclose any
> part of it. If you have received the message by mistake, please inform the
> sender of this and eliminate the message and any attachments it carries
> from your account.
>
>


ATOM RSS1 RSS2